111 related articles for article (PubMed ID: 16711759)
1. A simple approach for indexing the oral druglikeness of a compound: discriminating druglike compounds from nondruglike ones.
Biswas D; Roy S; Sen S
J Chem Inf Model; 2006; 46(3):1394-401. PubMed ID: 16711759
[TBL] [Abstract][Full Text] [Related]
2. Predicting oral druglikeness by iterative stochastic elimination.
Rayan A; Marcus D; Goldblum A
J Chem Inf Model; 2010 Mar; 50(3):437-45. PubMed ID: 20170135
[TBL] [Abstract][Full Text] [Related]
3. A scoring scheme for discriminating between drugs and nondrugs.
Sadowski J; Kubinyi H
J Med Chem; 1998 Aug; 41(18):3325-9. PubMed ID: 9719584
[TBL] [Abstract][Full Text] [Related]
4. Measuring CAMD technique performance. 2. How "druglike" are drugs? Implications of Random test set selection exemplified using druglikeness classification models.
Good AC; Hermsmeier MA
J Chem Inf Model; 2007; 47(1):110-4. PubMed ID: 17238255
[TBL] [Abstract][Full Text] [Related]
5. Development of reliable aqueous solubility models and their application in druglike analysis.
Wang J; Krudy G; Hou T; Zhang W; Holland G; Xu X
J Chem Inf Model; 2007; 47(4):1395-404. PubMed ID: 17569522
[TBL] [Abstract][Full Text] [Related]
6. A new rapid and effective chemistry space filter in recognizing a druglike database.
Zheng S; Luo X; Chen G; Zhu W; Shen J; Chen K; Jiang H
J Chem Inf Model; 2005; 45(4):856-62. PubMed ID: 16045278
[TBL] [Abstract][Full Text] [Related]
7. A large descriptor set and a probabilistic kernel-based classifier significantly improve druglikeness classification.
Li Q; Bender A; Pei J; Lai L
J Chem Inf Model; 2007; 47(5):1776-86. PubMed ID: 17718552
[TBL] [Abstract][Full Text] [Related]
8. ADME evaluation in drug discovery. 8. The prediction of human intestinal absorption by a support vector machine.
Hou T; Wang J; Li Y
J Chem Inf Model; 2007; 47(6):2408-15. PubMed ID: 17929911
[TBL] [Abstract][Full Text] [Related]
9. Gradual in silico filtering for druglike substances.
Schneider N; Jäckels C; Andres C; Hutter MC
J Chem Inf Model; 2008 Mar; 48(3):613-28. PubMed ID: 18269264
[TBL] [Abstract][Full Text] [Related]
10. Estimation of pKa for druglike compounds using semiempirical and information-based descriptors.
Jelfs S; Ertl P; Selzer P
J Chem Inf Model; 2007; 47(2):450-9. PubMed ID: 17381168
[TBL] [Abstract][Full Text] [Related]
11. Separating drugs from nondrugs: a statistical approach using atom pair distributions.
Hutter MC
J Chem Inf Model; 2007; 47(1):186-94. PubMed ID: 17238264
[TBL] [Abstract][Full Text] [Related]
12. Prediction and mechanistic interpretation of human oral drug absorption using MI-QSAR analysis.
Iyer M; Tseng YJ; Senese CL; Liu J; Hopfinger AJ
Mol Pharm; 2007; 4(2):218-31. PubMed ID: 17397237
[TBL] [Abstract][Full Text] [Related]
13. Computational prediction of oral drug absorption based on absorption rate constants in humans.
Linnankoski J; Mäkelä JM; Ranta VP; Urtti A; Yliperttula M
J Med Chem; 2006 Jun; 49(12):3674-81. PubMed ID: 16759110
[TBL] [Abstract][Full Text] [Related]
14. ADME evaluation in drug discovery. 7. Prediction of oral absorption by correlation and classification.
Hou T; Wang J; Zhang W; Xu X
J Chem Inf Model; 2007; 47(1):208-18. PubMed ID: 17238266
[TBL] [Abstract][Full Text] [Related]
15. Fingerprint-based clustering applied to define a QSAR model use radius.
Sprous DG
J Mol Graph Model; 2008 Sep; 27(2):225-32. PubMed ID: 18556228
[TBL] [Abstract][Full Text] [Related]
16. Bayesian screening for active compounds in high-dimensional chemical spaces combining property descriptors and molecular fingerprints.
Vogt M; Bajorath J
Chem Biol Drug Des; 2008 Jan; 71(1):8-14. PubMed ID: 18069988
[TBL] [Abstract][Full Text] [Related]
17. Genetic algorithm-optimized QSPR models for bioavailability, protein binding, and urinary excretion.
Wang J; Krudy G; Xie XQ; Wu C; Holland G
J Chem Inf Model; 2006; 46(6):2674-83. PubMed ID: 17125207
[TBL] [Abstract][Full Text] [Related]
18. The evolution of synthetic oral drug properties.
Proudfoot JR
Bioorg Med Chem Lett; 2005 Feb; 15(4):1087-90. PubMed ID: 15686918
[TBL] [Abstract][Full Text] [Related]
19. Molecular properties that influence oral drug-like behavior.
Lajiness MS; Vieth M; Erickson J
Curr Opin Drug Discov Devel; 2004 Jul; 7(4):470-7. PubMed ID: 15338956
[TBL] [Abstract][Full Text] [Related]
20. ADME evaluation in drug discovery. 6. Can oral bioavailability in humans be effectively predicted by simple molecular property-based rules?
Hou T; Wang J; Zhang W; Xu X
J Chem Inf Model; 2007; 47(2):460-3. PubMed ID: 17381169
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
